Hypo-oestrogenic and anabolic/androgenic side-effects of danazol are w
ell known by the gynaecologist and some of them are present in >50% of
patients being treated for endometriosis. Additionally, danazol produ
ces hepatocellular damage in similar to 10% of women. The present repo
rt describes the first case of acute pancreatitis associated with dana
zol treatment of endometriosis.